227 related articles for article (PubMed ID: 1315160)
1. Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
Tucker RM; Denning DW; Hanson LH; Rinaldi MG; Graybill JR; Sharkey PK; Pappagianis D; Stevens DA
Clin Infect Dis; 1992 Jan; 14(1):165-74. PubMed ID: 1315160
[TBL] [Abstract][Full Text] [Related]
2. Azole antifungal agents.
Bodey GP
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S161-9. PubMed ID: 1314105
[TBL] [Abstract][Full Text] [Related]
3. The triazole antifungal agents: a review of itraconazole and fluconazole.
Bailey EM; Krakovsky DJ; Rybak MJ
Pharmacotherapy; 1990; 10(2):146-53. PubMed ID: 2161523
[TBL] [Abstract][Full Text] [Related]
4. Oral azole drugs as systemic antifungal therapy.
Como JA; Dismukes WE
N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
[TBL] [Abstract][Full Text] [Related]
5. New antifungal agents for the systemic mycoses.
Ringel SM
Mycopathologia; 1990 Feb; 109(2):75-87. PubMed ID: 2157984
[TBL] [Abstract][Full Text] [Related]
6. Azole antifungal drugs: old and new.
Dismukes WE
Ann Intern Med; 1988 Aug; 109(3):177-9. PubMed ID: 2839058
[No Abstract] [Full Text] [Related]
7. Pharmacokinetic optimisation of oral antifungal therapy.
Schäfer-Korting M
Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
[TBL] [Abstract][Full Text] [Related]
8. Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations.
Tucker RM; Denning DW; Arathoon EG; Rinaldi MG; Stevens DA
J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):593-601. PubMed ID: 2170479
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activities of azole agents against the Malassezia species.
Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M
Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
[TBL] [Abstract][Full Text] [Related]
10. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans.
Shrestha SK; Grilley M; Anderson T; Dhiman C; Oblad J; Chang CW; Sorensen KN; Takemoto JY
Med Mycol; 2015 Nov; 53(8):837-44. PubMed ID: 26260746
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy.
Troke PF; Andrews RJ; Pye GW; Richardson K
Rev Infect Dis; 1990; 12 Suppl 3():S276-80. PubMed ID: 2184505
[TBL] [Abstract][Full Text] [Related]
12. Azole antifungal agents: emphasis on new triazoles.
Saag MS; Dismukes WE
Antimicrob Agents Chemother; 1988 Jan; 32(1):1-8. PubMed ID: 2831809
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Van Cutsem J
Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
[TBL] [Abstract][Full Text] [Related]
14. Antifungal agents. Part II. The azoles.
Terrell CL
Mayo Clin Proc; 1999 Jan; 74(1):78-100. PubMed ID: 9987539
[TBL] [Abstract][Full Text] [Related]
15. [Antifungal agent resistance of yeasts of clinical significance].
Odds FC
Rev Clin Esp; 1995 Oct; 195 Suppl 3():56-7. PubMed ID: 9441307
[No Abstract] [Full Text] [Related]
16. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H
Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
[TBL] [Abstract][Full Text] [Related]
17. Azoles, allylamines and drug metabolism.
Back DJ; Tjia JF; Abel SM
Br J Dermatol; 1992 Feb; 126 Suppl 39():14-8. PubMed ID: 1311943
[TBL] [Abstract][Full Text] [Related]
18. R 51211 (itraconazole) therapy of murine cryptococcosis.
Graybill JR; Ahrens J
Sabouraudia; 1984; 22(6):445-53. PubMed ID: 6098031
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity of ketoconazole and other azoles against Malassezia furfur in vitro and in vivo.
Strippoli V; Piacentini A; D'Auria FD; Simonetti N
Infection; 1997; 25(5):303-6. PubMed ID: 9334866
[TBL] [Abstract][Full Text] [Related]
20. Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
Viviani MA
Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]